IL286248A - מעכבי tyk2 והשימוש בהם - Google Patents
מעכבי tyk2 והשימוש בהםInfo
- Publication number
- IL286248A IL286248A IL286248A IL28624821A IL286248A IL 286248 A IL286248 A IL 286248A IL 286248 A IL286248 A IL 286248A IL 28624821 A IL28624821 A IL 28624821A IL 286248 A IL286248 A IL 286248A
- Authority
- IL
- Israel
- Prior art keywords
- tyk2 inhibitors
- tyk2
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962816698P | 2019-03-11 | 2019-03-11 | |
US201962835376P | 2019-04-17 | 2019-04-17 | |
US201962877741P | 2019-07-23 | 2019-07-23 | |
US201962931119P | 2019-11-05 | 2019-11-05 | |
PCT/US2020/021850 WO2020185755A1 (en) | 2019-03-11 | 2020-03-10 | Tyk2 inhibitors and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL286248A true IL286248A (he) | 2021-10-31 |
Family
ID=72427699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL286248A IL286248A (he) | 2019-03-11 | 2021-09-09 | מעכבי tyk2 והשימוש בהם |
Country Status (10)
Country | Link |
---|---|
US (1) | US20220177486A1 (he) |
EP (1) | EP3938369A4 (he) |
JP (1) | JP2022524974A (he) |
KR (1) | KR20210141973A (he) |
CN (1) | CN113811534A (he) |
AU (1) | AU2020239026A1 (he) |
BR (1) | BR112021017996A2 (he) |
CA (1) | CA3132632A1 (he) |
IL (1) | IL286248A (he) |
WO (1) | WO2020185755A1 (he) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11202104017VA (en) | 2018-10-22 | 2021-05-28 | Esker Therapeutics Inc | Tyk2 inhibitors and uses thereof |
SG11202110523XA (en) * | 2019-03-26 | 2021-10-28 | Ventyx Biosciences Inc | Tyk2 pseudokinase ligands |
WO2020233645A1 (zh) * | 2019-05-21 | 2020-11-26 | 浙江海正药业股份有限公司 | 大环类衍生物、及其制备方法和用途 |
MX2022005563A (es) | 2019-11-08 | 2022-08-19 | Ventyx Biosciences Inc | Ligandos de la pseudoquinasa tyk2. |
EP4214215A1 (en) * | 2020-09-16 | 2023-07-26 | Alumis Inc. | Tyk2 inhibitors and uses thereof |
CN114591351B (zh) * | 2020-12-03 | 2023-12-05 | 成都科岭源医药技术有限公司 | 一种多环化合物及其制备方法和用途 |
CA3236262A1 (en) | 2021-10-25 | 2023-05-04 | Isaac Marx | Tyk2 degraders and uses thereof |
WO2023178234A1 (en) * | 2022-03-16 | 2023-09-21 | Alumis Inc. | Tyk2 inhibitors and uses thereof |
WO2023178235A1 (en) * | 2022-03-16 | 2023-09-21 | Alumis Inc. | Tyk2 inhibitors and uses thereof |
WO2023208244A1 (zh) * | 2022-04-29 | 2023-11-02 | 南京明德新药研发有限公司 | 大环类化合物及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013001310A1 (en) * | 2011-06-30 | 2013-01-03 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Macrocyclic compounds and their use as cdk8 inhibitors |
UA121206C2 (uk) * | 2014-01-24 | 2020-04-27 | Турнінґ Поінт Терапьютикс, Інк. | Діарильні макроцикли як модулятори протеїнкіназ |
CN107735399B (zh) * | 2015-07-02 | 2021-01-26 | 特普医药公司 | 作为蛋白质激酶的调节剂的手性二芳基大环 |
JOP20190092A1 (ar) * | 2016-10-26 | 2019-04-25 | Array Biopharma Inc | عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها |
JOP20190213A1 (ar) * | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | مركبات حلقية ضخمة كمثبطات لكيناز ros1 |
MY201925A (en) * | 2017-07-28 | 2024-03-23 | Turning Point Therapeutics Inc | Macrocyclic compounds and uses thereof |
SG11202110523XA (en) * | 2019-03-26 | 2021-10-28 | Ventyx Biosciences Inc | Tyk2 pseudokinase ligands |
-
2020
- 2020-03-10 BR BR112021017996A patent/BR112021017996A2/pt unknown
- 2020-03-10 CN CN202080034800.9A patent/CN113811534A/zh active Pending
- 2020-03-10 AU AU2020239026A patent/AU2020239026A1/en active Pending
- 2020-03-10 KR KR1020217032541A patent/KR20210141973A/ko unknown
- 2020-03-10 EP EP20769748.3A patent/EP3938369A4/en active Pending
- 2020-03-10 US US17/438,329 patent/US20220177486A1/en active Pending
- 2020-03-10 JP JP2021552136A patent/JP2022524974A/ja active Pending
- 2020-03-10 CA CA3132632A patent/CA3132632A1/en active Pending
- 2020-03-10 WO PCT/US2020/021850 patent/WO2020185755A1/en unknown
-
2021
- 2021-09-09 IL IL286248A patent/IL286248A/he unknown
Also Published As
Publication number | Publication date |
---|---|
EP3938369A4 (en) | 2023-01-25 |
AU2020239026A1 (en) | 2021-09-23 |
BR112021017996A2 (pt) | 2021-11-16 |
US20220177486A1 (en) | 2022-06-09 |
KR20210141973A (ko) | 2021-11-23 |
CA3132632A1 (en) | 2020-09-17 |
WO2020185755A1 (en) | 2020-09-17 |
JP2022524974A (ja) | 2022-05-11 |
CN113811534A (zh) | 2021-12-17 |
EP3938369A1 (en) | 2022-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL282487A (he) | מעכבים מסוג tyk2 והשימוש בהם | |
IL271999A (he) | מעכבי tyk2 ושימושים בהם | |
IL283409A (he) | מעכבי tyk2 ושימושים בהם | |
IL282090A (he) | מעכבי tyk2 ושימושים בהם | |
IL286248A (he) | מעכבי tyk2 והשימוש בהם | |
IL284799A (he) | מעכבי tyk2 ושימושים בהם | |
IL265922A (he) | מעכבי tyk2 ושימושים בהם | |
IL288381A (he) | מעכבי tead ושימושים בהם | |
IL289534A (he) | מעכבים של parp1 | |
IL288384A (he) | מעכבי tead ושימושים בהם | |
IL266109A (he) | מעכבי tyk2 ושימושים בהם | |
HK1256997A1 (zh) | Tyk2抑制劑及其用途 | |
HK1248690A1 (zh) | 酪胺酸蛋白質激酶2(tyk2)抑制劑及其用途 | |
IL276095B1 (he) | מעכבי gcn2 ושימושים בם | |
IL276147A (he) | מעכבי gcn2 ושימושים בהם | |
EP4232425A4 (en) | CTPS1 INHIBITORS AND USES THEREOF | |
PT4031547T (pt) | Inibidores de calicreína plasmática e utilizações dos mesmos | |
IL282350A (he) | מעכבים ברנני-rgmc ושימוש בהם | |
PL3621694T3 (pl) | Inhibitory lrrc33 i ich zastosowanie | |
IL291217A (he) | מעכבי usp30 ושימושים שלהם | |
IL285595A (he) | מעכבים של spt5 ושימוש בהם | |
IL286622A (he) | מעכבי prmt5 ושימושים בהם | |
IL292198A (he) | מעכבים של tim-3 ושימושים שלהם | |
IL286485A (he) | מעכבי pi4-קיינאס ושיטות לשימוש בהן | |
GB201908884D0 (en) | Inhibitors and use |